We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Cookie Policy

Latest News

5

Mar 19

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

ST. LOUIS, March 5, 2019 /PRNewswire/ -- Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products...
Read More

9

Oct 18

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Canopy brings CRISPR technology within the reach of millions of researchers worldwide. Canopy BiosciencesTM, LLC, an established provider of gene...
Read More

22

May 18

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Venture Capital Financing for Canopy Biosciences

Startup to Advance Research Tools Development and Add Jobs ST. LOUIS – Canopy Biosciences has exceeded its Series A financing...
Read More

22

Feb 18

Canopy Biosciences featured in Nature Biotechnology

Canopy Bioscience was featured in the February 6 issue of Nature Biotechnology in an article on DIY gene editing. Our...
Read More
1 2 3 4
0

Start typing and press Enter to search